| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 7.43 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Background: The use of monoclonal antibodies (MABs) has been increasing in healthcare, namely, in the treatment of malignant and non-malignant diseases. These molecules are widely used in monotherapy and in chemotherapy cycles along with cytotoxic drugs. Currently, the use is also increasing in veterinary practice. Thus, a considerable number of health professionals (e.g. pharmacists and pharmacy technicians, nurses, veterinarians, physicians, and others) can be exposed to this new therapeutic class. Aim: To give an overview of the main guidelines to safe handling of MABs worldwide; To estimate the occupational risk of handling MABs in three Portuguese health institutions.
Descrição
Palavras-chave
Occupational health Occupational exposure Monoclonal bodies Health institution Portugal
Contexto Educativo
Citação
Costa-Veiga A, Viegas S. Occupational exposure to monoclonal antibodies in Portuguese health units: are there reasons for concern? In: EUROTOX 2019, Helsinki (Finland), September 11-19, 2019. Toxicol Lett. 2019;314 Suppl 1:s228.